Conferences & Events > Annual Scientific Meeting > Satellite Sessions > Pharmaco Satellite
ACMT will present two full-day Satellite Sessions on Thursday, April 11, preceding our Annual Scientific Meeting (April 12-14). Below is information for New Frontiers in Medical Toxicology: Pharmacogenomics and Precision Medicine. For information on the other Satellite Session, go to: Legal Cannabis: Medical, Toxicological and Public Health Implications. 
View/print Brochure

New Frontiers in Medical Toxicology: Pharmacogenomics and Precision Medicine

Precision and genomic medicine refers to the use of genetic or molecular profiling to optimize efficiency or therapeutic benefit for particular groups of patients. Although in some form, "precision medicine" has been a part of healthcare for many years, its role in day-to-day healthcare is expanding and evolving into exciting frontiers.

The Precision Medicine Initiative, supported by the NIH, includes investments in this emerging field of medicine that customizes healthcare based on clinical and genetic characteristics in order to improve outcomes. A major focus of NIH research is through the Pharmacogenomics Research Network which has already led to significant clinical impact through deeper understanding of genetic polymorphisms of CYP 450 and other genes responsible for drug metabolism, transport and elimination. These genetic differences explain why some patients respond favorably while others fail to respond to treatments or have life threatening adverse reactions.

This new frontier in medicine could have dramatic impact on the role of Medical Toxicologists who are poised to provide expertise in the realm of pharmacogenomics. A Medical Toxicologist’s ability to understand and interpret results of pharmacogenomics testing offers an innovative practice model that would solidify our role in the rapidly evolving field of precision and genomic medicine.

This conference is designed to provide attendees with the crucial scientific knowledge and current clinical implications of pharmacogenomics so that they can build and implement this innovative field of medicine into their current practice.


Register Now


Preliminary Agenda 

7:00 - 7:45 AM Registration
7:45 - 8:00 AM
Welcome & Opening Remarks
Ayrn O'Connor, MD, FACMT, FAAEM, Director, Medical Toxicology Fellowship, University of Arizona College of Medicine Phoenix Banner -- University Medical Center Phoenix
Meghan Beth Spyres, MD, Assistant Professor Of Clinical Emergency Medicine, Keck School of Medicine, University of Southern California
8:00 - 8:50 AM 
Human Genome Project: Pharmacogenomics and DNA
Teri Manolio, MD, PhD, Director, Division of Genomic Medicine, National Human Genome Research Institute
8:50 - 9:35 AM
Genetic Variations Impact on Drug Response: Current Trends and Research
Russ B. Altman, MD, PhD, Professor of Bioengineering, Genetics, Medicine, and Biomedical Data Science, Stanford University
9:35 - 10:05 AM
Precision Medicine and Databases: PharmGKB
Teri Klein, PhD, Professor of Biomedical Data Science and Medicine, Standford University
10:05 - 10:15 AM Break
10:15 - 10:45 AM
Pharmacogenomics of Analgesics: CYP 2D6
Andrew Monte, MD, PhD, Associate Professor Emergency Medicine and Medical Toxicology, University of Colorado
10:45 - 11:30 AM
Pharmacogenomics of Anticonvulsants: HLA & CYP2C9
Steven Curry, MD, Professor of Emergency Medicine, Internal Medicine and Biomedical Informatics
11:30 - 12:00 PM
Pediatric Pharmacogenomics: A New Frontier
12:00 - 1:15 PM Break for Lunch
1:15 - 1:45 PM
Laboratory Analysis & Methodology: What the Clinician Needs to Know
Shaun R. Opie, PhD, Co-founder & CSO, Vantari Genetics
1:45 - 2:15 PM
PGX: Challenges of Clinical Implementation
Kelly Caudle, PharmD, PhD, CPIC Director, St. Judes Children's Research Hospital
2:15 - 2:45 PM
Pharmacogenomics of Cardiovascular Drugs: CYP 2C19
Will Heise, MD, Assistant Professor, Division of Clinical Data Analytics and Decision Support, Department of Medical Toxicology, University of Arizona College of Medicine Phoenix Banner -- University Medical Center Phoenix
2:45 - 3:00 PM Break
3:00 - 4:00 PM Panel Discussion: How to Start a Clinical PGx Service

Event Fees

Early Bird Rates*
Deadline: February 1, 2019
Regular Rates
February 2 - April 11, 2019
Registration Category 
Registration Category 
ACMT Member $225 ACMT Member $275
Fellow-in-Training (FIT) $175 Fellow-in-Training (FIT) $225
Resident** $175 Resident** $225 
Medical Student** $150  Medical Student** $200 
Specialist in Poison Information (SPI) $175 Specialist in Poison Information (SPI) $225
Non-Member - Government & Military Personnel $225 Non-Member - Government & Military Personnel $275
Non-Member $300 Non-Member $350
Continuing Medical Education (CME) $75 Continuing Medical Education (CME) $75
Register Now
Satellite Session Access: when you register for the Pharmacogenomics Satellite Session, you get access to the Cannabis Satellite Session. Attendees are allowed to go back and forth between the two events and attend the lectures of their choosing. For registration purposes, select the Satellite you plan on attending the most.
*Early Bird Rates end at 11:59pm ET on February 1, 2019Fees increase to the Regular Rate after this date, no exceptions.
**Proof of student and resident status is required to confirm this rate. Proof consists of a copy of your student ID or a letter from your institution’s Registrar verifying student or resident status. Documentation must be received within two weeks of registering via email to or fax to (844) 226-8333. Attention: 2019 ASM. 
Cancellation Policy: Cancellations received in writing on or prior to January 31, 2019 are subject to a $150 processing fee. Refunds will not be granted after January 31, 2019. Please send cancellation request to ACMT at, or fax to 623-533-6520.
Consent to Use of Photographic Images: Registration and attendance at, or participation in, ACMT meetings and other activities constitutes an agreement by the registrant to ACMT's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions and audiotapes of such events and activities.

Continuing Medical Education (CME)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Alabama School of Medicine and the American College of Medical Toxicology. The University of Alabama School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Medical Education (CME) is pending for this activity. It is expected that the University of Alabama School of Medicine will designate this live activity for: 6.25 AMA PRA Category 1 credit(s)™


Write to:

Register Now